67
Views
6
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Daclizumab a novel corticosteroid-sparing therapy for asthma?

Evaluation of: Busse WW, Israel E, Nelson HS, et al. Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial. Am J Respir Crit Care Med 2008;178:1002-8

, MD PhD
Pages 369-371 | Published online: 09 May 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

David Gibeon & Andrew N Menzies-Gow. (2012) Targeting interleukins to treat severe asthma. Expert Review of Respiratory Medicine 6:4, pages 423-439.
Read now

Articles from other publishers (5)

Elizabeth Sam & Prashanth Athri. (2019) Web-based drug repurposing tools: a survey. Briefings in Bioinformatics 20:1, pages 299-316.
Crossref
Soheil Moosavinasab, Jeremy Patterson, Robert Strouse, Majid Rastegar-Mojarad, Kelly Regan, Philip R. O. Payne, Yungui Huang & Simon M. Lin. (2016) ?RE:fine drugs?: an interactive dashboard to access drug repurposing opportunities. Database 2016, pages baw083.
Crossref
Richard Warrington. (2010) Immunotherapy in asthma. Immunotherapy 2:5, pages 711-725.
Crossref
Marisha L. Cook & Bruce S. Bochner. (2010) Update on Biological Therapeutics for Asthma. World Allergy Organization Journal 3:6, pages 188-194.
Crossref
Umesh C. S. Yadav, Amarjit S. Naura, Leopoldo Aguilera-Aguirre, Kota V. Ramana, Istvan Boldogh, Sanjiv Sur, Hamid A. Boulares & Satish K. Srivastava. (2009) Aldose Reductase Inhibition Suppresses the Expression of Th2 Cytokines and Airway Inflammation in Ovalbumin-Induced Asthma in Mice. The Journal of Immunology 183:7, pages 4723-4732.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.